Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.07 - $31.84 $408,178 - $808,736
25,400 Added 173.97%
40,000 $1.16 Million
Q1 2024

May 15, 2024

SELL
$17.13 - $26.91 $263,802 - $414,414
-15,400 Reduced 51.33%
14,600 $301,000
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $647,400 - $885,000
30,000 New
30,000 $811,000
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $229,200 - $337,600
10,000 New
10,000 $234,000

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.56B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.